Form 8-K - Current report:
SEC Accession No. 0001104659-22-032029
Filing Date
2022-03-09
Accepted
2022-03-09 16:15:32
Documents
13
Period of Report
2022-03-03
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm228806d1_8k.htm   iXBRL 8-K 30591
2 EXHIBIT 16.1 tm228806d1_ex16-1.htm EX-16.1 2493
  Complete submission text file 0001104659-22-032029.txt   206319

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA twst-20220303.xsd EX-101.SCH 3054
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE twst-20220303_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE twst-20220303_pre.xml EX-101.PRE 22609
7 EXTRACTED XBRL INSTANCE DOCUMENT tm228806d1_8k_htm.xml XML 3479
Mailing Address 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 800-719-0671
Twist Bioscience Corp (Filer) CIK: 0001581280 (see all company filings)

EIN.: 462058888 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38720 | Film No.: 22725539
SIC: 2836 Biological Products, (No Diagnostic Substances)